# Section 219: Tranexamic Acid (TXA)

---

Tranexamic Acid (TXA)
230
Tranexamic Acid (TXA)
Mechanism of Action
Displaces plasminogen from fibrin, inhibiting fibrinolysis (clot breakdown). Has inhibitory effects on plasmin, preventing further fibrinolysis.
Uses
Trauma associated hemorrhage, menorrhagia, tooth extraction in hemophiliac patients
Contraindications
IV: Hypersensitivity to tranexamic acid, active intravascular clotting, subarachnoid hemorrhage
PO: hypersensitivity to tranexamic acid, active thromboembolic disease, concurrent use with hormonal contraception
Protocol Uses
OB / Vaginal Bleeding – Adult (p51), Head Injury – Adult (p80), Hemorrhage Control – Adult (p81), Hypotension / Shock (Trauma) – Adult (p85), Head Injury –
Peds (p126), Hemorrhage Control – Peds (p127)
IV indicated for trauma associated hemorrhage
PO indicated for menorrhagia, tooth extraction in hemophiliac patients
Side Effects
CNS: Headache (PO), Dizziness (IV)
CV: Hypotension (IV)
GI: Abdominal pain (PO), Diarrhea, nausea, vomiting (IV)
Heme: thromboembolic complications (i.e. DVT), anemia (PO)
Misc: Backache (PO), blurred vision (IV and PO)
Pharmacokinetics
Onset of Action: IV: 5 minutes, PO: 2.5 hours
Excretion: Renal
Half-life: IV: 2 hours, PO: 11 hours
Pregnancy Category – B
Interactions
May enhance tranexamic acid: Estrogen derivatives,
progestins
EMT Considerations
Assess: Hypersensitivity
Evaluate: Serial Blood Pressure, Mental Status, HR
Treatment of Overdose
Discontinue product, supportive care
Pharmaceuticals
B EMT
A A-EMT
P Paramedic
M Medical Control
EMR
